INC On Demand: Extend Your Educational Impact Year-Round

AAD’s Industry Non-CME (INC) On Demand gives companies a powerful opportunity to share high-quality, company-led educational content with dermatologists and other healthcare professionals — long after the Annual Meeting concludes.

Hosted within the AAD Learning Center and mobile app, this program extends the reach of your scientific and disease-state education, delivering sustained visibility across AAD’s trusted digital ecosystem.

What Is INC On Demand?

INC On Demand is a dedicated digital hub inside the AAD Learning Center, featuring non-CME educational content developed by industry sponsors under AAD’s compliance standards.

Sponsors can host professionally produced, final-approved assets such as:

• Recorded symposia and expert discussions

• Disease education videos and treatment animations

• Case studies, adherence tools, and clinical resources

• Branded or unbranded educational PDFs

• Microsites

Each asset remains accessible for 12 months, ensuring continuous engagement across AAD’s high-traffic channels.

Why participate in INC On Demand?

With over 34,000 Learning Center users — including 12,000+ AAD members — INC On Demand provides unmatched access to a highly targeted, highly engaged dermatology audience.

Key benefits include:

• Featured placement within the INC On Demand Hub

• Visibility across homepage banners, and Learning Center carousels

• Promotion through AAD channels including newsletters, DermWorld digital, and mobile app alerts

• Quarterly engagement analytics, including completions, views, downloads, and click-throughs

• Sponsor branding permitted under AAD review and guardrails

INC On Demand uniquely extends your educational reach beyond a single event, creating meaningful, year-round visibility.

Quality, Compliance & Review

All INC On Demand content is:

• Non-CME, submitted in final form, and reviewed by AAD for balance and accuracy

• Displayed with required AAD disclaimers and topic guardrails

• On-label, scientifically appropriate, and aligned with FDA, OIG, Pharmacode, and AdvaMed guidelines

AAD does not edit sponsor-produced content; sponsors must submit final approved materials.

Need help determining the best fit or have questions about the review process? Email our team at: incprograms@aad.org